| VLP16-ELISA |
NA-HPV16 |
NA-PsV16 |
N of women |
VLP18-ELISA |
NA-HPV18 |
NA-PsV18 |
N of women |
| + |
+ |
+ |
7 |
+ |
+ |
+ |
4 |
| + |
+ |
- |
11 |
+ |
+ |
- |
3 |
| + |
- |
+ |
3 |
+ |
- |
+ |
0 |
| + |
- |
- |
12 |
+ |
- |
- |
6 |
| - |
+ |
+ |
9 |
- |
+ |
+ |
11 |
| - |
+ |
- |
21 |
- |
+ |
- |
23 |
| - |
- |
+ |
6 |
- |
- |
+ |
5 |
| - |
- |
- |
25 |
- |
- |
- |
46 |
|
+: Seropositive
-: Seronegative |
| Table 2: The distribution of seropositivity results across the 3 assays. |
